Company Filing History:
Years Active: 2006-2009
Title: The Innovations of René Rijnbrand
Introduction
René Rijnbrand is a notable inventor based in Galveston, TX (US). He has made significant contributions to the fields of biochemistry, molecular biology, and virology. His work primarily focuses on the identification and study of viruses, particularly in relation to hepatitis.
Latest Patents
Rijnbrand holds a patent for a chimeric GB virus B (GBV-B). This invention relates to the identification of GB virus B/HCV chimeras. It involves nucleic acid constructs and compositions encoding GBV-B/HCV chimera, including at least part of a 5' NTR derived from a HCV 5' NTR. This construct, along with its chimeric versions, is utilized to study GBV-B and related hepatitis family members, such as the hepatitis C virus. The invention encompasses methods of preparing GBV-B/HCV chimeric sequences, constructs, and viruses, as well as methods of employing these compositions. Rijnbrand's innovative approach has the potential to advance research in virology.
Career Highlights
Throughout his career, Rijnbrand has worked with prestigious institutions, including the University of Texas System and Institut Pasteur. His experience in these organizations has allowed him to collaborate with leading experts in the field.
Collaborations
Rijnbrand has collaborated with notable colleagues such as Annette Martin and David V Sangar. These partnerships have contributed to the advancement of his research and the development of his patented inventions.
Conclusion
René Rijnbrand's contributions to virology and molecular biology are significant, particularly through his patented work on GB virus B. His innovative research continues to impact the scientific community and enhance our understanding of viral diseases.